Healthy Adult Subjects — Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets
Citation(s)
A Phase 1, Open-Label, 3-Period, Randomized, Single-Dose, Crossover Study to Assess the Relative Bioavailability and the Effect of Food on the Pharmacokinetics of a New 15 mg Tablet of Losmapimod Versus the Current 7.5 mg Tablet